Literature DB >> 10073685

Identification of neutralizing epitopes on a European strain of swine vesicular disease virus.

S K Nijhar, D K Mackay, E Brocchi, N P Ferris, R P Kitching, N J Knowles.   

Abstract

Six neutralizing monoclonal antibodies (MAbs) were used to isolate MAb neutralization-resistant (MAR) mutants from a recent European strain of swine vesicular disease virus (SVDV), ITL/9/93. Sequencing of MAR mutants identified two epitopes located at positions analogous to sites 2A (VP2) and 3B (VP3) on poliovirus (PV) which have been previously identified on a Japanese strain of SVDV. A third epitope near to the C terminus of VP1, not previously recognized on SVDV, was tentatively identified in a region analogous to site 1 of PV. A fourth epitope, located in the C-terminal region of VP3, has never before been recognized as a site of neutralization on picornaviruses. All four epitopes were predicted to be surface-exposed.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10073685     DOI: 10.1099/0022-1317-80-2-277

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  8 in total

1.  Expression and immunological analysis of capsid protein precursor of swine vesicular disease virus HK/70.

Authors:  Hong Tian; Jing-yan Wu; You-jun Shang; Shuang-hui Ying; Hai-xue Zheng; Xiang-tao Liu
Journal:  Virol Sin       Date:  2010-06-06       Impact factor: 4.327

2.  Noninfectious virus-like particle antigen for detection of swine vesicular disease virus antibodies in pigs by enzyme-linked immunosorbent assay.

Authors:  Young-Joon Ko; Kang-Seuk Choi; Jin-Ju Nah; David J Paton; Jae-Ku Oem; Ginette Wilsden; Shien-Young Kang; Nam-In Jo; Joo-Ho Lee; Jae-Hong Kim; Hee-Woo Lee; Jong-Myeong Park
Journal:  Clin Diagn Lab Immunol       Date:  2005-08

3.  The N-terminal region of the VP1 protein of swine vesicular disease virus contains a neutralization site that arises upon cell attachment and is involved in viral entry.

Authors:  M A Jiménez-Clavero; E Escribano-Romero; A J Douglas; V Ley
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

4.  Characterization of a putative ancestor of coxsackievirus B5.

Authors:  Maria Gullberg; Conny Tolf; Nina Jonsson; Mick N Mulders; Carita Savolainen-Kopra; Tapani Hovi; Marc Van Ranst; Philippe Lemey; Susan Hafenstein; A Michael Lindberg
Journal:  J Virol       Date:  2010-07-14       Impact factor: 5.103

5.  Structure of swine vesicular disease virus: mapping of changes occurring during adaptation of human coxsackie B5 virus to infect swine.

Authors:  Núria Verdaguer; Miguel A Jimenez-Clavero; Ignacio Fita; Victoria Ley
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

6.  Crystal structure of Swine vesicular disease virus and implications for host adaptation.

Authors:  Elizabeth E Fry; Nick J Knowles; John W I Newman; Ginette Wilsden; Zihe Rao; Andrew M Q King; David I Stuart
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

7.  Generation, characterization, and application in serodiagnosis of recombinant swine vesicular disease virus-like particles.

Authors:  Wanhong Xu; Melissa Goolia; Tim Salo; Zhidong Zhang; Ming Yang
Journal:  J Vet Sci       Date:  2017-08-31       Impact factor: 1.672

8.  Molecular analysis of echovirus 13 isolates and aseptic meningitis, Spain.

Authors:  Ana Avellón; Inmaculada Casas; Gloria Trallero; Carmen Pérez; Antonio Tenorio; Gustavo Palacios
Journal:  Emerg Infect Dis       Date:  2003-08       Impact factor: 6.883

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.